Research Methodology:

Top-down and bottom-up approaches were used to validate the size of the global Hepatitis Test Solution Market and estimate the size of various other dependent sub-markets. Major players in the market were identified through secondary research, and their market revenues were determined through primary and secondary research. Secondary sources include annual reports, press releases, and investor presentations of companies; white papers; medical journals; certified publications; articles from recognized authors; gold standard and silver standard websites; directories; and databases.

In-depth interviews were conducted with various primary respondents, such as key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as to assess future prospects.

This data is consolidated and added to detailed inputs and analysis from MarketsandMarkets and presented in this report. Some of the secondary resources referred to are World Health Organization (WHO), National Institutes of Health (NIH), National Center for Biotechnology Information (NCBI), US FDA, Parenteral Drug Association (PDA), International Society for Pharmaceutical Engineering (ISPE), and Washington Biotechnology & Biomedical Association (WBBA).

Download the PDF Brochure for More Details@ http://bit.ly/2AFW54v

The global hepatitis test solution/diagnosis market is estimated to account for USD 2.66 billion in 2018 and is projected to reach USD 3.37 billion by 2023, at a CAGR of 4.9%. Initiatives taken by government and non-government organizations, high burden of hepatitis worldwide, increasing number of blood transfusions & donations, and benefits offered by point of care instruments & kits are the major factors driving this market.

Collaborations, agreements, and partnerships remain at the center of the strategic growth initiatives adopted by most of the key players in the global hepatitis test solution/diagnosis market. Companies such as Abbott Laboratories, Roche Diagnostics, Bio-Rad, DiaSorin, Danaher, and Grifols have been focusing on this inorganic strategy to enhance their market presence. Players also adopted product launches, product approval, and acquisition as growth strategies.

Roche Diagnostics was the largest player in the hepatitis testing market. The company offers a wide range of test kits and systems. The firm mainly focuses on R&D investment and product launches & approvals. In 2017, the company invested ~13% of its total revenue in R&D to develop new product offerings. Geographically, the company operates in different countries across North America, Latin America, Europe, the Middle East, Africa, and Asia. Roche also focuses on collaborations to enhance its market presence.

Abbott Laboratories is an important player in the global hepatitis testing market. The company offers a wide range of products, including assays & reagents, systems, and informatics solutions & services. Abbott focuses on strengthening its position in the market by adopting organic strategies, such as collaborations, agreements, partnerships, and acquisitions. In 2018, the company entered into partnerships with pathology and research centers to expand its geographical presence across the globe.

Some other leading players in the global hepatitis test solution/diagnosis market include Bio-Rad (US), Siemens (Germany), DiaSorin (Italy), QIAGEN (Netherlands), Danaher (US), bioMérieux (France), and Grifols (Spain). These companies have well-established sales and distribution networks across the globe. They also make significant investments in R&D activities to develop innovative technologies and products. Focus on innovation plays an important role in this market.

You Can Also Request to Get the Customized Information on This Research Study

Target Audience:

• Blood banks
• Pathologists and pathology laboratories
• Distributors of IVD products
• Research institutes
• Hospitals and clinics
• Healthcare institutions
• Group purchasing organizations (GPOs)
• Market research and consulting firms

Scope of the Report:

The research report categorizes the global hepatitis test solution/diagnosis market into the following segments and sub-segments:

Hepatitis test solution/diagnosis Market, by Disease type:

• Hepatitis B
• Hepatitis C
• Other Disease type

Hepatitis test solution/diagnosis Market, by Technology:

• ELISA
• Rapid Diagnostics test
• PCR
• INAAT
• Other Technologies

Hepatitis test solution/diagnosis Market, by End User:

• Hospitals & Diagnostics Labs
• Blood Banks
• Other end user

Hepatitis test solution/diagnosis Market, by Region:

• North America
  • US
  • Canada
• Europe
  • Germany
  • UK
  • RoE
• Asia Pacific (APAC)
• Rest of the World (RoW)

Read More@
https://www.marketsandmarkets.com/Market-Reports/hepatitis-test-solution-market-139802887.html